Congenital Hypothyroidism: A 2020–2021 Consensus Guidelines Update—An ENDO-European Reference Network Initiative Endorsed by the European Society for Pediatric Endocrinology and the European Society for Endocrinology
A S Paul van Trotsenburg(Emma Kinderziekenhuis), Michel Polak(Délégation Paris 5), Luisa De Sanctis, Dominique Luton(Délégation Paris 7), Gabor Szinnai(University Children’s Hospital Basel), Tilman Rohrer(Saarland University), Philip Murray(Manchester Academic Health Science Centre), Mariacarolina Salerno(University of Naples Federico II), Laura Fugazzola(University of Milan), Juliane Léger(Hôpital Robert-Debré), Patrice Rodien(Inserm), Beate Bartès(European Patent Organisation), Alessandra Cassio(IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola), Heiko Krude(Humboldt-Universität zu Berlin), Catherine Peters(Great Ormond Street Hospital), Luca Persani(University of Milan), Joachim Pohlenz(Johannes Gutenberg University Mainz), R. Coutant(Centre Hospitalier Universitaire de Tours), Mariacristina Vigone(Vita-Salute San Raffaele University), Athanasia Stoupa(Hôpital Necker-Enfants Malades), Véronique Beauloye(Cliniques Universitaires Saint-Luc), Claudine Heinrichs(Queen Fabiola Children's University Hospital)
Cited by 455
Related Papers
Severe early-onset obesity, adrenal insufficiency and red hair pigmentation caused by POMC mutations in humans
|Nature Genetics|1998|1.7k
Association between mutations in a thyroid hormone transporter and severe X-linked psychomotor retardation
|The Lancet|2004|707
European Society for Paediatric Endocrinology Consensus Guidelines on Screening, Diagnosis, and Management of Congenital Hypothyroidism
|The Journal of Clinical Endocrinology & Metabolism|2014|569
PAX8 mutations associated with congenital hypothyroidism caused by thyroid dysgenesis
|Nature Genetics|1998|503
Proopiomelanocortin Deficiency Treated with a Melanocortin-4 Receptor Agonist
|New England Journal of Medicine|2016|480